

HY-173047 · 50 mg
MedChemExpress · Cat: HY-173047
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/krasg12c-in-15.html
Description
KRASG12C IN-15 Compound 21 is the orally active inhibitor for KRASG12C, and inhibits SOS1-mediated GDP/GTP exchange with an IC50 of 19 nM. KRASG12C IN-15 inhibits the phosphorylation of ERK with IC50 of 0.051 ?M. KRASG12C IN-15 inhibits the cell viability of KRASG12C mutated MIA PaCa-2 with IC50 of 0.023 ?M. KRASG12C IN-15 exhibits antitumor effect in MIA PaCa-2 xenograft mouse models.







